Eiser A R, Slifkin R F, Neff M S
Am J Kidney Dis. 1987 Jul;10(1):71-3. doi: 10.1016/s0272-6386(87)80015-x.
Two maintenance hemodialysis patients receiving deferoxamine to chelate iron and aluminum developed intestinal mucormycosis. One patient had pulmonary mucormycosis as well. The patients lacked the usual predisposing factors to mucormycosis, ie, diabetes and acidosis, but both had liver disease. The role of siderophores such as deferoxamine in promoting certain infections is discussed with reference to this particular clinical setting.
两名接受去铁胺螯合铁和铝治疗的维持性血液透析患者发生了肠道毛霉病。其中一名患者还患有肺毛霉病。这两名患者缺乏毛霉病常见的易感因素，如糖尿病和酸中毒，但两人均患有肝脏疾病。结合这一特殊临床情况，讨论了去铁胺等铁载体在促进某些感染方面的作用。
